Provenge Cancer Vaccine: Can You Put a Price on Delaying Death?

By
Nathan
on July 29, 2010 3:01 PM |

With the advent of Provenge, the first-ever vaccine cancer treatment, that tag has been set at about $23,000 per month of life gained -- $93,000 in total for a treatment that extends life, on average, by four months.  Read more at abcnews.com

Categories:

The views expressed in the articles on this website are the opinions of the respective author and do not reflect the views of the Karen E. Mumford Cancer Foundation or it's Board of Directors.

© 2012 Karen E. Mumford Cancer Foundation